Net Cash Provided by (Used in) Financing Activities of BIOADAPTIVES, INC. from 30 Sep 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOADAPTIVES, INC. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Sep 2013 to 31 Dec 2024.
  • BIOADAPTIVES, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was $0, a 100% decline year-over-year.
  • BIOADAPTIVES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $326,211, a 26% increase from 2023.
  • BIOADAPTIVES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $259,144, a 53% increase from 2022.
  • BIOADAPTIVES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $169,728, a 28% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BIOADAPTIVES, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $326,211 +$67,067 +26% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $259,144 +$89,416 +53% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $169,728 -$67,272 -28% 01 Jan 2022 31 Dec 2022 10-K 10 Apr 2024 2023 FY
2021 $237,000 +$137,837 +139% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $99,163 -$25,055 -20% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $124,218 -$301,782 -71% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $426,000 01 Jan 2018 31 Dec 2018 10-K/A 12 May 2020 2019 FY
2015 $37,700 -$117,172 -147% 01 Jan 2015 31 Dec 2015 10-K 14 Apr 2016 2015 FY
2014 $79,472 +$41,884 +111% 01 Jan 2014 31 Dec 2014 10-K 14 Apr 2016 2015 FY
2013 $37,588 19 Apr 2013 31 Mar 2014 10-Q 20 May 2014 2014 Q1

BIOADAPTIVES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $0 -$34,010 -100% 01 Jan 2023 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q1 2022 $34,010 -$45,990 -57% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $80,000 +$38,350 +92% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $41,650 +$31,650 +316% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q1 2019 $10,000 01 Jan 2019 31 Mar 2019 10-Q/A 11 Jun 2020 2020 Q1
Q1 2016 $1,753 +$36,507 01 Jan 2016 31 Mar 2016 10-Q 23 May 2016 2016 Q1
Q1 2015 $34,754 01 Jan 2015 31 Mar 2015 10-Q 23 May 2016 2016 Q1
Q3 2013 $749 01 Jul 2013 30 Sep 2013 10-Q 21 Oct 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.